Favorable longterm outcomes of liver transplant recipients treated de novo with once-daily tacrolimus: Results of a single-center cohort

Mikel Gastaca; Andrés Valdivieso; Javier Bustamante; José R. Fernández; Patricia Ruiz; Alberto Ventoso; Milagros Testillano; Ibone Palomares; Patricia Salvador; Mikel Prieto; Miguel Montejo; María J. Suárez; Jorge Ortiz de Urbina

doi:10.1002/lt.24514

Favorable longterm outcomes of liver transplant recipients treated de novo with once-daily tacrolimus: Results of a single-center cohort

Liver Transplantation ◽

10.1002/lt.24514 ◽

2016 ◽

Vol 22 (10) ◽

pp. 1391-1400 ◽

Cited By ~ 9

Author(s):

Mikel Gastaca ◽

Andrés Valdivieso ◽

Javier Bustamante ◽

José R. Fernández ◽

Patricia Ruiz ◽

...

Keyword(s):

Liver Transplant ◽

De Novo ◽

Transplant Recipients ◽

Single Center ◽

Once Daily ◽

Liver Transplant Recipients

Download Full-text

A single‐center, open‐label, randomized cross‐over study to evaluate the pharmacokinetics and bioavailability of once‐daily prolonged‐release formulations of tacrolimus in de novo liver transplant recipients

Immunity Inflammation and Disease ◽

10.1002/iid3.537 ◽

2021 ◽

Author(s):

Uta Herden ◽

Martina Sterneck ◽

Bettina M. Buchholz ◽

Eike G. Achilles ◽

Armin Ott ◽

...

Keyword(s):

Liver Transplant ◽

De Novo ◽

Prolonged Release ◽

Transplant Recipients ◽

Single Center ◽

Open Label ◽

Once Daily ◽

Liver Transplant Recipients

Download Full-text

Betel quid chewing leads to the development of unique de novo malignancies in liver transplant recipients, a retrospective single center study in Taiwan

Medicine ◽

10.1097/md.0000000000004901 ◽

2016 ◽

Vol 95 (37) ◽

pp. e4901 ◽

Cited By ~ 3

Author(s):

Yi-Chan Chen ◽

Chih-Hsien Cheng ◽

Yu-Chao Wang ◽

Ting-Jun Wu ◽

Hong-Shiue Chou ◽

...

Keyword(s):

Liver Transplant ◽

De Novo ◽

Betel Quid ◽

Transplant Recipients ◽

Single Center ◽

Single Center Study ◽

Betel Quid Chewing ◽

Liver Transplant Recipients ◽

Center Study

Download Full-text

Single Center Experiences of Conversion from Twice-daily Tacrolimus (Prograf) to Once-daily Tacrolimus (Advagraf) in Stable Liver Transplant Recipients

The Journal of the Korean Society for Transplantation ◽

10.4285/jkstn.2016.30.2.77 ◽

2016 ◽

Vol 30 (2) ◽

pp. 77

Author(s):

Tae-Seok Kim ◽

Keun Soo Ahn ◽

Yong Hoon Kim ◽

Hyoung Tae Kim ◽

Koo Jeong Kang

Keyword(s):

Liver Transplant ◽

Transplant Recipients ◽

Single Center ◽

Once Daily ◽

Liver Transplant Recipients

Download Full-text

Comparison of Extended-Release, Once Daily Tacrolimus and Standard Twice Daily Tacrolimus in De Novo Liver Transplant Recipients

10.26226/morressier.58eb975cd462b80290b4fd8c ◽

2017 ◽

Author(s):

Tiong Yeng Lim

Keyword(s):

Liver Transplant ◽

Extended Release ◽

De Novo ◽

Transplant Recipients ◽

Once Daily ◽

Liver Transplant Recipients

Download Full-text

INTERIM ANALYSIS OF A SINGLE-CENTER, PROSPECTIVE, RANDOMIZED TRIAL COMPARING TACROLIMUS VERSUS CYCLOSPORINE IMMUNOSUPPRESSION USING 2 HOUR POST DOSE (C2) MONITORING IN DE NOVO LIVER TRANSPLANT RECIPIENTS

Transplantation Journal ◽

10.1097/00007890-200407271-01011 ◽

2004 ◽

Vol 78 ◽

pp. 377-378 ◽

Cited By ~ 1

Author(s):

K L. Hardinger ◽

W C. Chapman ◽

J Lowell ◽

N Desai ◽

J Crippin ◽

...

Keyword(s):

Liver Transplant ◽

Randomized Trial ◽

Interim Analysis ◽

De Novo ◽

Prospective Randomized Trial ◽

Transplant Recipients ◽

Single Center ◽

Post Dose ◽

C2 Monitoring ◽

Liver Transplant Recipients

Download Full-text

Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients: A single-center experience with 394 patients

Liver Transplantation ◽

10.1002/lt.23638 ◽

2013 ◽

Vol 19 (5) ◽

pp. 529-533 ◽

Cited By ~ 14

Author(s):

Jérôme Dumortier ◽

Olivier Guillaud ◽

Olivier Boillot

Keyword(s):

Liver Transplant ◽

Transplant Recipients ◽

Single Center ◽

Once Daily ◽

Single Center Experience ◽

Liver Transplant Recipients

Download Full-text

Efficacy and Safety Evaluation After Conversion From Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplant Recipients: A Phase 4, Open-Label, Single-Center Study

Transplantation Proceedings ◽

10.1016/j.transproceed.2021.09.043 ◽

2021 ◽

Author(s):

Woo-Hyoung Kang ◽

Gi-Won Song ◽

Deok-Bog Moon ◽

Shin Hwang ◽

Ki-Hun Kim ◽

...

Keyword(s):

Liver Transplant ◽

Safety Evaluation ◽

Efficacy And Safety ◽

Transplant Recipients ◽

Single Center ◽

Open Label ◽

Once Daily ◽

Single Center Study ◽

Liver Transplant Recipients ◽

Center Study

Download Full-text

PHARMACOKINETICS (PK) OF TACROLIMUS FOR A ONCE DAILY PROLONGED RELEASE FORMULATION (ADVAGRAF®) VERSUS TWICE-DAILY (PROGRAF®) IN DE NOVO LIVER TRANSPLANT RECIPIENTS IN A PHASE III MULTICENTRE STUDY

Transplantation Journal ◽

10.1097/01.tp.0000332467.76453.c8 ◽

2008 ◽

Vol 86 (Supplement) ◽

pp. 127 ◽

Cited By ~ 1

Author(s):

N Undre ◽

B-G Ericzon ◽

E Varo ◽

P Trunecka ◽

X Rogiers ◽

...

Keyword(s):

Multicentre Study ◽

Liver Transplant ◽

De Novo ◽

Phase Iii ◽

Prolonged Release ◽

Transplant Recipients ◽

Release Formulation ◽

Once Daily ◽

Liver Transplant Recipients

Download Full-text

A Prospective, Multicenter Study of Once-Daily Extended-Release Tacrolimus in De Novo Liver Transplant Recipients

Transplantation Proceedings ◽

10.1016/j.transproceed.2011.01.093 ◽

2011 ◽

Vol 43 (3) ◽

pp. 718-723 ◽

Cited By ~ 5

Author(s):

R. Charco ◽

M. Caralt ◽

L. Lladó ◽

A. Valdivieso ◽

J. Fabregat ◽

...

Keyword(s):

Liver Transplant ◽

Multicenter Study ◽

Extended Release ◽

De Novo ◽

Transplant Recipients ◽

Prospective Multicenter Study ◽

Once Daily ◽

Liver Transplant Recipients

Download Full-text

PKP-019 Experience of once daily tacrolimus individualised dosing through a bayesian approach in de novo liver transplant recipients

10.1136/ejhpharm-2017-000640.447 ◽

2017 ◽

Author(s):

P Más-Serrano ◽

ML Boquera Ferrer ◽

R Nalda-Molina ◽

M Díaz González ◽

G Rodríguez-Laiz ◽

...

Keyword(s):

Liver Transplant ◽

Bayesian Approach ◽

De Novo ◽

Transplant Recipients ◽

Once Daily ◽

Liver Transplant Recipients ◽

Individualised Dosing

Download Full-text